Ferritin - A mediator of apoptosis?

Journal of Cellular Physiology

Volumn 212, Issue 1, 2007, Pages 157-164

  Bresgen, Nikolaus ^a   Ohlenschläger, Ingo ^a   Fiedler, Brigitte ^a   Wacht, Nathalie ^a   Zach, Susanne ^a   Dunkelmann, Bettina ^a   Arosio, Paolo ^b   Kuffner, Elisabeth ^c   Lottspeich, Friedrich ^c   Eckl, Peter M ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b UNIVERSITY OF BRESCIA   (Italy)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; FAS LIGAND; FERRITIN; FERRITIN ANTIBODY; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; LIVER CELL; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SEQUENCE HOMOLOGY; TANDEM MASS SPECTROMETRY;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; FEMALE; FERRITINS; HEPATOCYTES; MITOCHONDRIA; RATS; RATS, INBRED F344; SIGNAL TRANSDUCTION; TIME FACTORS;

RATTUS;

EID: 34249863631     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21009     Document Type: Article

References (42)

1. Arosio P, Adelman TG, Drysdale JW. 1978. On ferritin heterogeneity. Further evidence for heteropolymers. J Biol Chem 253:4451-4458.
2. Bailly-Maitre B, da Sousa G, Zucchini N, Gugenheim J, Boulukos KE, Rahmani R. 2002. Spontaneous apoptosis in primary cultures of human and rat hepatocytes: Molecular mechanisms and regulation by dexamethasone. Cell Death Differ 9:945-955.
3. Bresgen N, Rolinek R, Hochleitner E, Lottspeich F, Eckl PM. 2004. Induction of apoptosis by a hepatocyte conditioned medium. J Cell Physiol 198:452-460.
4. Broxmeyer H, Bognacki J, Dorner M, de Sousa M. 1981. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages. J Exp Med 153:1426-1444.
5. Broxmeyer HE, Bognacki J, Ralph P, Dorner MH, Lu L, Castro-Malaspina H. 1982. Monocyte-macrophage-derived acidic isoferritins: Normal feedback regulators of granulocyte-macrophage progenitor cells in vitro. Blood 60:595-607.
6. Cozzi A, Levi S, Bazzigaluppi E, Ruggeri G, Arosio P. 1989. Development of an immunoassay for all human isoferritins, and its application to serum ferritin evaluation. Clin Chim Acta 184:197-206.
7. Dezza L, Cazzola M, Piacibello W, Arosio P, Levi S, Aglietta M. 1986. Effect of acidic and basic isoferritins on in vitro growth of human granulocyte-monocyte progenitors. Blood 67:789-795.
8. Dezza L, Cazzola M, Bergamaschi G, Stella CC, Pedrazzoli P, Recalde HR. 1988. Effects of recombinant human H-subunit and L-subunit ferritins on in vitro growth of human granulocyte-monocyte progenitors. Br J Haematol 68:367-372.
9. Eckl PM, Whitcomb WR, Michalopoulos G, Jirtle RL. 1987. Effects of EGF and calcium on adult parenchymal hepatocyte proliferation. J Cell Physiol 132:363-366.
10. Erster S, Moll UM, 2005. Stress-induced p53 runs a transcription- independent death program. Biochem Biophys Res Commun 331:843-850.
11. Erster S, Mihara M, Kim RH, Petrenko O, Moll UM. 2004. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death responses DNA damage that can precede p53 target gene activation. Mol Cell Biol 24:6728-6741.
12. Ethier C, Raymond V-A, Musallam L, Houle R, Bilodeau M. 2003. Antiapoptotic effect of EGF on mouse hepatocytes associated with downregulatlon of proapoptotic Bid protein. Am J Physiol Gastrointest Liver Physiol 285:G298-G308.
13. Fausto N, Laird AD, Webber EM. 1995. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 9:1527-1536.
14. Garty B, Kaminsky E, Moroz C. 1995. The immunosuppressive human placental ferritin subunit p43 is produced by activated CD4+ lymphocytes. Clin Diagn Lab Immunol 2:225-226.
15. Ghosh S, Hevi S, Chuck SL. 2004. Regulated secretion of glycosylated human ferritin from hepatocytes. Blood 103:2369-2376.
16. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. 1995. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology 21:1465-1468.
17. Gray CP, Franco AV, Arosio P, Hersey P. 2001. Immunosuppressive effects of melanoma-derived heavy-chain ferritin are dependent on stimulation of IL-10 production. Int J Cancer 92:843-850.
18. Gross A, Yin X-M, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P, Korsmeyer SJ. 1999. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-RI/Fas death. J Biol Chem 274:1156-1163.
19. Jauniaux E, Maymon R, Greenwold N, Hustin J, Moroz C. 2000. Diminished expression of placental isoferritin p43 component in first trimester abnormal pregnancies. Placenta 21:408-411.
20. Johnson DA, Lardy HA. 1967. Isolation of liver and kidney mitochondria. In: Estabook RW, Pullman M, editors. Methods in enzymology, New York: Academic Press. 10: pp 4-96.
21. Konikoff F, Shoenfeld Y, Isenberg DA, Theodor F, Moroz C. 1987. Placental type isoferritins in chronic liver diseases. Hepatogastroenterology 34:65-67.
22. Li H, Zhu H, Xu CJ, Yuan J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501.
23. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490.
24. Marchenko ND, Zalka A, Moll UM. 2000. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275: 16202-16212.
25. Maymon R, Moroz C. 1996. Placental isoferritin: A new biomarker from conception to delivery. Br J Obstet Gynaecol 103:301-305.
26. Maymon R, Jauniaux E, Greenwold N, Traub L, Moroz C. 2000. Detection of the Immunoregulator p43-placental isoferritin in the human embryo and fetus. Mol Hum Reprod 6:843-848.
27. Michalopoulos G, Cianciulli HD, Novotny AR, Kligerman AD, Strom SC, Jirtle RL. 1982. Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res 42:4673-4682.
28. Moroz C, Kupfer B, Twig S, Parhami-Seren B. 1985. Preparation and characterization of monoclonal antibodies specific to placenta ferritin. Clin Chim Acta 148:111-118.
29. Moroz C, Bessler H, Lurie Y, Shaklai M. 1987. New monoclonal antibody enzymoassay for the specific measurement of placental ferritin isotype in hematologic malignancies. Exp Hematol 15:258-262.
30. Moroz C, Traub L, Maymon R, Zahalka MA. 2002. PLIF, a novel human ferritin subunit from placenta with immunosuppressive activity. J Biol Chem 277:12901-12905.
31. Moroz C, Grunspan A, Zahalka MA, Traub L, Kodman Y, Yaniv I. 2006. Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks. Exp Hematol. 34:159-166.
32. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR. 1997. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99:403-413.
33. Musallam L, Ethier C, Haddad PS, Bilodeau M. 2001. Role of EGF receptor tyrosine kinase activity in antiapoptotic effect of EGF on mouse hepatocytes. Am J Physiol Gastrointest Liver Physiol 280:G1360-G1369.
34. Nahum R, Brenner O, Zahalka MA, Traub L, Quintana F, Moroz C. 2004. Blocking of the placental immune-modulatory ferritin activates Th1 type cytokines and affects placenta development, fetal growth and the pregnancy outcome. Hum Reprod 19:715-722.
35. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R. 1992. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci USA 89:5408-5412.
36. Rosen HR. 1996. Placental isoferritin-associated p43 in pregnancy and breast cancer. Minireview Neoplasma 43:357-362.
37. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME. 1999. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274:22532-2253B.
38. Sirota L, Kupfer B, Moroz C. 1989. Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy. Clin Exp Immunol 77:257-262.
39. Spector DL, Goldman RD, Leinwand LA. 1998. Isolation of mitochondria. In: Cells: A laboratory manual. Vol. I. Cold Spring Harbour: Cold Spring Harbour Laboratory Press.
40. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. 1997. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and Iron. Blood 90:4979-4986.
41. Weinberger A, Halpern M, Zahalka MA, Quintana F, Traub L, Moroz C. 2003. Placental immunomodulator ferritin, a novel immunoregulator, suppresses experimental arthritis. Arthritis Rheum 48:846-853.
42. Zahalka MA, Bank V, Traub L, Moroz C. 2003. PLIF induces IL-10 production in monocytes: A calmodulin-p38 mitogen-activated protein kinase-dependent pathway. FASEB J 17:955-957.